POS-044 ECULIZUMAB INTERRUPTION IN KIDNEY TRANSPLANT RECIPIENTS WITH ATYPICAL HEMOLYTIC UREMIC SYNDROME: ANALYSIS OF A BRAZILIAN SHORTAGE

Autor: NETO, M., Soler, L., Vasconcelos, H., Si Nga, H., Bravin, A., Quinino, R., Santana, V.B., Palma, L., Andrade, L.G.
Zdroj: In Kidney International Reports June 2022 7(6) Supplement:S457-S457
Databáze: ScienceDirect